I would expect/hope that we are already producing for them if they expect approval in May. That is just my hopeum. From a previous post of mine from the ASM:
An interesting comment from the operations guy was that after approval, but before commercial launch, the customer will likely want a stockpile of their drug to ensure no hiccups during launch.
Of course, we may not know until the next quarterly CC.
When we announced a while back that we signed a contract with one of the top ten Pharmas, that contract was for us to be a secondary/backup producer of a biologic. We never did receive any updates on that, but I am hoping that that could be it....